Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer. Chen D, Cai B, Zhu Y, Ma Y, et al. Clin Epigenetics 2024;16:51.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen D, Cai B, Zhu Y, Ma Y, et al. Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer. Clin Epigenetics 2024;16:51.
PMID: 38576048